194 related articles for article (PubMed ID: 12384593)
1. 'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents.
Yu D; Kandimalla ER; Bhagat L; Tang JY; Cong Y; Tang J; Agrawal S
Nucleic Acids Res; 2002 Oct; 30(20):4460-9. PubMed ID: 12384593
[TBL] [Abstract][Full Text] [Related]
2. A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif.
Kandimalla ER; Bhagat L; Zhu FG; Yu D; Cong YP; Wang D; Tang JX; Tang JY; Knetter CF; Lien E; Agrawal S
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14303-8. PubMed ID: 14610275
[TBL] [Abstract][Full Text] [Related]
3. Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles.
Kandimalla ER; Bhagat L; Wang D; Yu D; Zhu FG; Tang J; Wang H; Huang P; Zhang R; Agrawal S
Nucleic Acids Res; 2003 May; 31(9):2393-400. PubMed ID: 12711684
[TBL] [Abstract][Full Text] [Related]
4. Potent CpG oligonucleotides containing phosphodiester linkages: in vitro and in vivo immunostimulatory properties.
Yu D; Zhu FG; Bhagat L; Wang H; Kandimalla ER; Zhang R; Agrawal S
Biochem Biophys Res Commun; 2002 Sep; 297(1):83-90. PubMed ID: 12220512
[TBL] [Abstract][Full Text] [Related]
5. Conjugation of ligands at the 5'-end of CpG DNA affects immunostimulatory activity.
Kandimalla ER; Bhagat L; Yu D; Cong Y; Tang J; Agrawal S
Bioconjug Chem; 2002; 13(5):966-74. PubMed ID: 12236778
[TBL] [Abstract][Full Text] [Related]
6. CpG penta- and hexadeoxyribonucleotides as potent immunomodulatory agents.
Bhagat L; Zhu FG; Yu D; Tang J; Wang H; Kandimalla ER; Zhang R; Agrawal S
Biochem Biophys Res Commun; 2003 Jan; 300(4):853-61. PubMed ID: 12559951
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and immunostimulatory properties of CpG DNAs containing alkyl-linker substitutions: role of nucleosides in the flanking sequences.
Yu D; Kandimalla ER; Cong Y; Tang J; Tang JY; Zhao Q; Agrawal S
J Med Chem; 2002 Sep; 45(20):4540-8. PubMed ID: 12238933
[TBL] [Abstract][Full Text] [Related]
8. Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice.
Zhu FG; Kandimalla ER; Yu D; Tang JX; Agrawal S
Int Immunopharmacol; 2004 Jul; 4(7):851-62. PubMed ID: 15182725
[TBL] [Abstract][Full Text] [Related]
9. Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin.
Adamsson J; Lindblad M; Lundqvist A; Kelly D; Holmgren J; Harandi AM
J Immunol; 2006 Apr; 176(8):4902-13. PubMed ID: 16585586
[TBL] [Abstract][Full Text] [Related]
10. Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells.
Du HY; Xia SY; Song HF; Li N; Shang MM; Zou J; Wang QQ; Ou L; Sun X; Ji AG; Tang ZM
Acta Pharmacol Sin; 2007 Oct; 28(10):1637-44. PubMed ID: 17883951
[TBL] [Abstract][Full Text] [Related]
11. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
[TBL] [Abstract][Full Text] [Related]
12. Immunostimulatory activity of CpG oligonucleotides containing non-ionic methylphosphonate linkages.
Yu D; Kandimalla ER; Zhao Q; Cong Y; Agrawal S
Bioorg Med Chem; 2001 Nov; 9(11):2803-8. PubMed ID: 11597460
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Toll-like Receptor 9 Responses through Synthetic Immunostimulatory Motifs of DNA.
Agrawal S; Kandimalla ER
Ann N Y Acad Sci; 2003 Dec; 1002():30-42. PubMed ID: 14751820
[TBL] [Abstract][Full Text] [Related]
14. P-chirality-dependent immune activation by phosphorothioate CpG oligodeoxynucleotides.
Krieg AM; Guga P; Stec W
Oligonucleotides; 2003; 13(6):491-9. PubMed ID: 15025915
[TBL] [Abstract][Full Text] [Related]
15. Requirement of nucleobase proximal to CpG dinucleotide for immunostimulatory activity of synthetic CpG DNA.
Yu D; Kandimalla ER; Zhao Q; Bhagat L; Cong Y; Agrawal S
Bioorg Med Chem; 2003 Feb; 11(3):459-64. PubMed ID: 12517441
[TBL] [Abstract][Full Text] [Related]
16. CpG RNA: identification of novel single-stranded RNA that stimulates human CD14+CD11c+ monocytes.
Sugiyama T; Gursel M; Takeshita F; Coban C; Conover J; Kaisho T; Akira S; Klinman DM; Ishii KJ
J Immunol; 2005 Feb; 174(4):2273-9. PubMed ID: 15699162
[TBL] [Abstract][Full Text] [Related]
17. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs.
Wang D; Li Y; Yu D; Song SS; Kandimalla ER; Agrawal S
Int J Oncol; 2004 Apr; 24(4):901-8. PubMed ID: 15010828
[TBL] [Abstract][Full Text] [Related]
18. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.
Hartmann G; Weeratna RD; Ballas ZK; Payette P; Blackwell S; Suparto I; Rasmussen WL; Waldschmidt M; Sajuthi D; Purcell RH; Davis HL; Krieg AM
J Immunol; 2000 Feb; 164(3):1617-24. PubMed ID: 10640783
[TBL] [Abstract][Full Text] [Related]
19. Conjugation of lipid and CpG-containing oligonucleotide yields an efficient method for liposome incorporation.
Andrews CD; Provoda CJ; Ott G; Lee KD
Bioconjug Chem; 2011 Jul; 22(7):1279-86. PubMed ID: 21612239
[TBL] [Abstract][Full Text] [Related]
20. Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3' sequence modifications.
Zimmermann S; Heeg K; Dalpke A
Vaccine; 2003 Feb; 21(9-10):990-5. PubMed ID: 12547613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
